AzTrials
AzTrials

Psychiatric ProblemNCT04792671

Prevalence and Risk Factors of Women Mental Health Disorders

An observational study of Psychiatric Problem and Wolman Disease, run by Assiut University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Perinatal major depressive disorder affects 20% of women, while perinatal anxiety affects 10% of women. Although pharmacological treatment has shown effectiveness, many pregnant women are concerned about potential adverse effects on the fetus, maternal-infant bonding, and child development.. Read more about this study

Who is it for?
Ages 18 to 50 years, women onlyHealthy volunteers can take part
Conditions the study is for
Psychiatric Problem, Wolman Disease
What is being tested?
Sociodemographic variables, Family affluence scale (FAS) and Edinburgh postnatal depression scale (EPDS)
How many people
200 participants
Where
No sites listed yet
Study dates
1 Mar 2021to 1 Sep 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: This is study will take part in the Assiut government primary health centres in community

Who may be able to join

  • age 18 years -50 years.
  • No previous history of psychiatric, neurological or medical disease

Who cannot join

  • intelligence equation less than 80
  • have history of psychiatric, neurological or medical disease

Trial locations and contacts

No sites are listed yet.

About this study

Official title: Prevalence and Risk Factors of Women Mental Health Disorders in Assiut Governorate

Perinatal major depressive disorder affects 20% of women, while perinatal anxiety affects 10% of women. Although pharmacological treatment has shown effectiveness, many pregnant women are concerned about potential adverse effects on the fetus, maternal-infant bonding, and child development.. On the other hand, Depressive disorder in women mainly occurs during the first year after childbirth. It takes many forms according to the onset, severity, and duration of the symptoms including; Postpartum blues (PPB), Postpartum depression (PPD), and Postpartum psychosis (PPP). Lack of access to mental health services during the perinatal period is a significant public health concern that may worse outcome.

So, we aimed to study prevalence of women mental health in Assiut governorate and evaluate possible risk factor for it

Being tested
Sociodemographic variables, Family affluence scale (FAS), Edinburgh postnatal depression scale (EPDS), Symptom Checklist 90 "SCL 90":
Keywords
women, mental health
Medical subject headings
Wolman Disease, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sociodemographic variablesBehavioural

    age, residence, education of the mother and her husband, occupation of the mother and her husband, parity, gender, and age of the last baby.

  • Family affluence scale (FAS)Behavioural

    a four-item measure of family wealth, has been developed in the WHO Health Behaviour in School-aged Children Study as an alternative measure.

  • Edinburgh postnatal depression scale (EPDS)Behavioural

    s a questionnaire originally developed to assist in identifying possible symptoms of depression in the postnatal period. It also has adequate sensitivity and specificity to identify depressive symptoms in the antenatal period and is useful in identifying symptoms of anxiety. more than 9 is clinically diagnosed

  • Symptom Checklist 90 "SCL 90":Behavioural

    is a 90-item questionnaire used to assess psychological problems. It is designed to evaluate a broad range of psychological problems and symptoms of psychopathology. More than 60 is considered clinically diagnosed

Study groups in NCT04792671
Study groupRoleWhat they receive
Perinatal groupfemales who are pregnancy
Receives: Behavioral: Sociodemographic variables; Behavioral: Family affluence scale (FAS); Behavioral: Edinburgh postnatal depression scale (EPDS); Behavioral: Symptom Checklist 90 "SCL 90":
postpartum groupfemale who get delivery(from day 1 up to 1 year)
Receives: Behavioral: Sociodemographic variables; Behavioral: Family affluence scale (FAS); Behavioral: Edinburgh postnatal depression scale (EPDS); Behavioral: Symptom Checklist 90 "SCL 90":

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. measure the prevalence of DSM 5 psychiatric disorders in perinatal and postnatal

    Measured: through study completion, an average of 1 year

  2. measure of risk factor of DSM 5 psychiatric disorders in perinatal and postnatal

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Mar 2021
  2. Study start1 Mar 2021 (estimated)
  3. Primary completion1 Sep 2022 (estimated)
  4. Study completion1 Sep 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04792671
Sponsor's protocol ID
women mental health disorders
Status last verified
Mar 2021
First submitted
8 Mar 2021
Last updated
11 Mar 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Sambrook Smith M, Lawrence V, Sadler E, Easter A. Barriers to accessing mental health services for women with perinatal mental illness: systematic review and meta-synthesis of qualitative studies in the UK. BMJ Open. 2019 Jan 24;9(1):e024803. doi: 10.1136/bmjopen-2018-024803.

    PubMed 30679296
  • Sheffield KM, Woods-Giscombe CL. Efficacy, Feasibility, and Acceptability of Perinatal Yoga on Women's Mental Health and Well-Being: A Systematic Literature Review. J Holist Nurs. 2016 Mar;34(1):64-79. doi: 10.1177/0898010115577976. Epub 2015 Apr 20.

    PubMed 25896571
  • Sharma V, Burt VK. DSM-V: modifying the postpartum-onset specifier to include hypomania. Arch Womens Ment Health. 2011 Feb;14(1):67-9. doi: 10.1007/s00737-010-0182-2. Epub 2010 Sep 25.

    PubMed 20872155

Questions about this trial

What is this clinical trial studying?

An observational study of Psychiatric Problem and Wolman Disease, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact gellan Ahmed (+201093663928, gillankaram@aun.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

measure the prevalence of DSM 5 psychiatric disorders in perinatal and postnatal (time frame: through study completion, an average of 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04792671, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2021; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in